• Research & Development

  Medication Aids Kidneys Function in PH Patients with Heart Disease and Renal Impairment

  Posted by Pulmonary Hypertension News Moderator on September 4, 2018 at 5:31 pm

  Levosimendan, soon starting a Phase 2 study for PH-HFpEF patients, was seen to benefit the kidneys in those with cardiorenal syndrome in a Phase 3 trial.

  Read more about this study here.

  What are your thoughts on this news?

  replied 7 years, 6 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply